Breaking News
Investing Pro 0
⏰ React to the Market Faster with Custom, Real-Time News Get Started

Joe Jordan

Joined: 25/11/16

Comments by Joe Jordan
EasyJet Jan 25, 2023 3:06AM ET
Now gradually recovering. Today 500 GBP
Plug Power Jan 10, 2023 2:59PM ET
20$ at January end
Tff Pharma Dec 30, 2022 5:49PM ET
Now is 1.05 USD
Palladium Dec 28, 2022 3:44AM ET
Target 1900
K&S AG Mar 01, 2022 1:48AM ET
Russia and Belarus alone produce 30% of all the world's fertilizer. K&S will continue to increase significantly over the medium term. It still has an affordable price.
K&S AG Mar 01, 2022 1:34AM ET
Where can it go? Now around 23 euro
Autogrill Feb 16, 2022 11:03AM ET
Time to recover from COVID and fly versus 10 euros (now less then 7)
K&S AG Feb 15, 2022 5:06PM ET
other good news: Russia announced it will stop exporting ammonium nitrate for two months. The chemical compound is used in the agriculture industry as a fertiliser to boost yields for crops like corn, cotton and wheat. Russia is reportedly responsible for around 62 percent of global production
ImmunoGen Nov 30, 2021 10:15AM ET
ImmunoGen Stock Soars On Positive Data From Ovarian Cancer Drug TrialImmunoGen said mirvetuximab, its treatment for patients with platinum-resistant ovarian cancer, performed well in a pivotal SORAYA trial. Mirvetuximab had a confirmed objective response rate (ORR) of 32.4%, the drugmaker said, with a duration of response (DOR) of 5.9 months in the 106-person trial.
Ocuphire Pharma Nov 25, 2021 12:39AM ET
Analyst Matthew Caufield set a price target of $26 on the stock, outlining four reasons for doing so. The company's shares are currently 38% above Tuesday's close at $4.81 but initially rose to a high of $5.50. The first of the four reasons for the rating is Ocuphire's phase 3 MIRA-2 trial's positive topline results for Nyxol. The analyst said that it presents an "opportune timing to get into the name prior to further program validation," which it expects in the near term. He also said a key differentiation of using Nyxol was another positive for the stock, adding that Ocuphire's APX3330 treatment for diabetic retinopathy is undervalued. "With Ocuphire completing a reverse merger with legacy oncology platform Rexahn Pharmaceuticals, and listing on NASDAQ in November 2020, we maintain invest
Eyepoint Pharma Nov 18, 2021 6:12AM ET
EyePoint Pharma secures $100M capital raise via equity offering
Eyepoint Pharma Nov 16, 2021 1:57AM ET
Yesterday value moved from 14.0 to 21.5 and during the day moved back to 14.3 dollars
Eyepoint Pharma Nov 16, 2021 1:54AM ET
Shares of EyePoint Pharmaceuticals Inc. reached a new 52-week intraday high after the company reported positive data from its Phase 1 DAVIO study of EYP-1901 in Wet AMD and announced plans to move forward to additional Phase 2 clinical trials in 2022.
Tff Pharma Aug 13, 2021 3:56AM ET
Now is 7.75
Petroleo Brasileiro Petrobras ADR Jun 08, 2021 3:01PM ET
Marcus, at which amount do you reckon we should sell?
K&S AG May 26, 2021 5:22AM ET
Any target price for the end of 2021?Now is 10.5 euro
Spirit Aerosystems May 16, 2021 10:19AM ET
Can this company go back to 80?
Kraft Heinz May 16, 2021 10:17AM ET
Can this company go back to 80?
Petroleo Brasileiro Petrobras ADR May 16, 2021 10:15AM ET
Can this company go back to 15?
GSK plc May 16, 2021 8:15AM ET
Which is the target in 1 year time? Now it is 1,37
Saipem May 16, 2021 8:13AM ET
Can this company go back to 5? Now it is around 2 but it has plenty of potential to fly
Autogrill May 16, 2021 8:12AM ET
Can this company go back to 10? Now it is around 7 but it has plenty of potential to fly
Leonardo May 16, 2021 8:10AM ET
Can this company go back to 11?Now it is 7 and it has plenty of potential to fly
UniCredit May 16, 2021 8:08AM ET
Can this come back to 15? Now is around 10 but it has plenty of potential to fly
Tff Pharma Mar 11, 2021 9:44AM ET
Any target price for TFF? Now is 17.10 USD